FEATURE ARTICLES
Bringing the API supply chain closer to home not only strengthens the supply chain for U.S. drug makers, but it also strengthens the U.S. reserve of critical medicines.
- Avoiding Alcohol-Induced Dose Dumping In Oral Drug Formulation
- Reimagining Psychedelics: Mental Wellness Without the Roadblocks
- How AI Is Revolutionizing Quality Management Systems
- Lean Manufacturing Implementation In Pharmaceutical Injectable Facilities
- July 2025 — CDMO Opportunities And Threats Report
- Gedatolisib Shatters Phase 3 Goals and Scales For Breast Cancer Breakthrough
- EMA Issues Revised Annex 11, New Annex 22, And Associated Documents On Data Governance
PHARMA ONLINE WHITE PAPERS
-
ICH Q12 Implementation: Regulatory Intelligence And PACM Agility
Here, we outline a practical framework designed to assist companies in implementing ICH Q12 from day one, enabling them to realize its benefits early on and paving the way for continuous improvement.
-
Isolators For Pharmacy Compounding – Time For Change?3/14/2025
Maintaining a contamination-free environment is crucial in drug compounding. Learn how isolator systems can improve safety, efficiency, and regulatory compliance.
-
Validation And Qualification Approach In New Annex 1 Revision2/21/2025
The new Annex 1 revision emphasizes validation and qualification for sterile drug production. Ensure product quality and contamination control by learning about in-depth requirements for premises and equipment.
-
Could RFID-Based Unit-Level Traceability Be Key To Operational Excellence?9/5/2023
Radiofrequency identification (RFID)-based unit-level tracking solutions for prefilled syringes are poised to help pharma manufacturers address key risks and costly bottlenecks related to the fill-finish process.
-
Driving Efficiency In QC Labs9/21/2023
Here, we examine the cause and impact of common errors in Quality Control (QC) labs, the strategy for reducing those errors with an intuitive chromatography system, and more.
-
Digital Maturity In Life Sciences Quality And Manufacturing6/17/2025
Innovators in life sciences manufacturing drive life-saving breakthroughs. Amid strict regulations and complex challenges, learn how your dedication ensures quality and pushes the boundaries of what’s possible in public health.
PHARMA ONLINE APP NOTES & CASE STUDIES
- Re-Imagining Chromatography: Building Efficient Downstream Processes
- A Transient Cell Line To Produce rAAV With Low-Level hcDNA Encapsidation
- Rheological Properties Of Pharmaceutical Excipients: Lactose Monohydrate And Carboxymethyl Cellulose
- Demonstrating The Performance Of A Robust HPLC System
- Analysis Of Drug-Excipient Incompatibility In Discovery And Formulation Development
NEWSLETTER ARCHIVE
- 08.29.25 -- George Tidmarsh Named CDER Director
- 08.28.25 -- Is Your Pharma Facility Ready For The Next Public Health Crisis?
- 08.28.25 -- STREAM Edition: Designing Facilities For Single-Use Systems
- 08.27.25 -- Learn how to enhance productivity in your monoclonal antibody (mAb) capture process
- 08.27.25 -- Meet Top CDMOs With Available Capacity For Tailored Solutions
INDUSTRY NEWS
-
AbbVie Enters Psychedelic Market With Bretisilocin Acquisition
Bretisilocin is a next-generation psychedelic compound (5-HT2A receptor agonist and 5-HT releaser) designed to exert a shorter duration of psychoactive experience, while retaining an extended therapeutic benefit
-
J&J Commits $2 Billion To N.C. Manufacturing Facility
J&J’s latest announcement follows its commitment in March to invest $55 billion to support U.S. manufacturing, R&D, and technology over the next four years.
-
FDA Launches PreCheck Program
The program introduces a two-phase approach to enable new U.S. drug manufacturing facilities: The Facility Readiness Phase and the Application Submission Phase.
-
President Trump Demands MFN Prices In Manufacturer Letters
President Trump has sent out a letter to 17 major pharmaceutical manufacturers, asking them to commit to lower prices by Sept. 29, 2025, or he plans to deploy every tool in his arsenal to protect American families.
-
Bristol Myers Squibb Forms Immunology Company With Finance Partner
The NewCo pipeline will start with three clinical-stage and two phase 1-ready investigational medicines that each target mechanisms in autoimmune diseases.
PHARMACEUTICAL ONLINE CONTENT COLLECTIONS

The modern microbiology laboratory is starting to look very different from the laboratory of even 10 years ago. The work will be similar, yet technology will have advanced. Automation, in particular, is taking center stage. Check out the latest e-book from Pharmaceutical Online.
More Content CollectionsSUPPLIER NEWS
-
ROSS DPM-150 Double Planetary Mixer Designed For High-Volume Production In Hazardous Locations8/28/2025
A well-proven tool for robust mixing of high-viscosity materials, the ROSS Double Planetary Mixer delivers exceptional performance through its unique agitation system and adaptability, while meeting explosion-proof requirements. The Model DPM-150 is a heavy-duty mixer that can process formulations ranging from 20 to 150 gallons, with viscosities exceeding 6 million centipoise. It is one of several ROSS production models serving thousands of pharmaceutical, aerospace, adhesives, sealants, composites, and specialty chemical manufacturing plants around the world.
-
OPTEL Acquires Vanguard Robotics To Accelerate Innovation In Pharma Automation8/28/2025
OPTEL Group, a global leader in pharmaceutical traceability and supply chain solutions, proudly announces the acquisition of Vanguard Robotics, an expert in end-of-line collaborative robot (cobot) automation. This strategic move reinforces OPTEL’s commitment to innovation and positions the company at the forefront of pharmaceutical automation.
-
Federal Equipment Company And Proxio Group Announce Equipment Auction With Capsule Fillers, Fluid Bed Dryers, Agilent HPLC Systems, Lyophilizers, Roller Compactors, Etc.8/27/2025
Federal Equipment Company, in conjunction with Proxio Group, is hosting a global online auction featuring capsule fillers, fluid bed dryers, Agilent HPLC systems, various lab pumps, lyophilizers, Vector roller compactors, M&O Perry fillers & more for your every need.
-
RABS Vs Pharmaceutical Isolators: Which Technology Is Best For An Efficient Contamination Control Strategy?8/26/2025
The publication of the new GMP Annex 1 has redefined the standards for managing aseptic processes, with the primary objective of minimizing contamination risks. This revision reflects the evolution of sterile processes and products, which are becoming increasingly diverse and complex, and the need for pharmaceutical companies to comply with stricter regulatory requirements.
-
Genentech And Roche Breaks Ground On New Drug Manufacturing Facility In Holly Springs NC8/26/2025
Genentech, a member of the Roche Group (SIX: RO, ROG; OTCQX: RHHBY), today broke ground on its newest U.S. manufacturing site in Holly Springs, North Carolina. This significant development marks the establishment of Genentech’s first manufacturing facility on the East Coast.